Literature DB >> 9548269

Deferoxamine arrests in vitro the proliferation of porcine hepatocyte in G1 phase of the cell cycle.

N Chenoufi1, G Baffet, B Drénou, S Cariou, M Desille, B Clément, P Brissot, G Lescoat, O Loréal.   

Abstract

Iron is required for cell proliferation of all living species. Moreover, iron excess may be involved in the development of hepatocellular carcinoma. In this study we analyzed the effects of deferoxamine, an iron chelator, on normal porcine hepatocyte proliferation. We confirmed that hepatocytes isolated from young pigs proliferate in the presence of insulin and fetal calf serum as shown by [3H] methyl-thymidine incorporation, presence of mitotic figures and increase in cell number. This was paralleled by nuclear expression of p34cdc2 and its associated histone H1 kinase activity. In the presence of deferoxamine, [3H] methyl-thymidine incorporation, expression of nuclear proteins (p34cdc2 and PCNA) and H1 kinase activity were drastically reduced. In addition, in contrast with control cultures, cells in S-phase were not detected by flow cytometry. These data suggest that iron chelation by deferoxamine can arrest the progression of porcine hepatocytes in the G1 phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548269     DOI: 10.1111/j.1600-0676.1998.tb00128.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.

Authors:  Gyesoon Yoon; Hyun-Jung Kim; Young-Sil Yoon; Hyeseong Cho; In K Lim; Jae-Ho Lee
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  Deferoxamine accelerates endothelial progenitor cell senescence and compromises angiogenesis.

Authors:  Yi-Nan Lee; Hsueh-Hsiao Wang; Cheng-Huang Su; Hsin-I Lee; Yen-Hung Chou; Chin-Ling Hsieh; Wen-Ting Liu; Kuo-Tung Shu; Kai-Ting Chang; Hung-I Yeh; Yih-Jer Wu
Journal:  Aging (Albany NY)       Date:  2021-09-11       Impact factor: 5.682

3.  Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine.

Authors:  Kana Komoto; Takahiro Nomoto; Sjaikhurrizal El Muttaqien; Hiroyasu Takemoto; Makoto Matsui; Yutaka Miura; Nobuhiro Nishiyama
Journal:  Cancer Sci       Date:  2020-11-29       Impact factor: 6.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.